Market Overview:
The global brain pacemaker market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of neurological disorders, technological advancements in brain pacemakers, and rising awareness about brain pacemakers. Based on type, the global brain pacemaker market is segmented into single channel and dual channel. The dual channel segment is expected to grow at a higher CAGR than the single channel segment during the forecast period from 2018 to 2030. This growth can be attributed to the increasing use of dual channel brain pacemakers for treating various neurological disorders. Based on application, the global brain pacemaker market is divided into dystonia, epilepsy, essential tremor, obsessive-compulsive disorder (OCD), Parkinson's disease (PD), and others.
Product Definition:
A brain pacemaker is a medical device that sends electrical impulses to the brain. These impulses help to regulate the activity of the brain and can improve symptoms of conditions such as Parkinson's disease, epilepsy, and dystonia.
Single Channel:
Single channel is a method of delivering electrical signals to the heart muscle through only one pathway. It is also known as single-channel stimulation and it has gained popularity in recent years due to technological advancements and better clinical outcomes.
In earlier days, cardiac pacemakers were made up of metal and had electrodes that were connected to the external pulse generator.
Dual Channel:
Dual channel is a method used to improve the reliability of pacemakers. It involves the use of two independent pathways for delivering electrical signals to pace setpoint generators. This helps in increasing the accuracy and consistency of heart rate sensing, which is an essential component in brain pacemaker design.
The dual-channel approach has been around for more than a decade but only recently has it started gaining traction among manufacturers as well as patients themselves.
Application Insights:
The others segment held the largest share of the global brain pacemaker market in 2017. This segment includes Parkinson¢â‚¬â„¢s disease, essential tremors, and other disorders. The growing prevalence of neurological disorders is expected to drive demand for brain pacemakers over the forecast period. According to a study published in 2016 by WHO, it was estimated that around 60 million people across the world have some form of epilepsy with about 50 million suffering from partial seizures annually.
Regional Analysis:
North America dominated the global brain pacemaker market in 2017. This can be attributed to the presence of a large number of patients suffering from neurodegenerative and psychiatric disorders, increasing healthcare expenditure, technological advancements in devices used for long-term therapy, and rising awareness about brain pacemakers. Moreover, an increase in FDA approvals for new products is also expected to drive growth during the forecast period.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure due to government initiatives and an increase in disposable income that would lead towards higher adoption rates of technologically advanced medical devices among individuals suffering from cardiac disorders resulting into high demand for these products over next eight years. Furthermore, China has become one of the largest markets globally with more than 50% share owing to its huge population base requiring continuous monitoring & treatment options thereby driving growth across this region.
Growth Factors:
- Increasing prevalence of neurological disorders: The global prevalence of neurological disorders is increasing at a significant rate. This is primarily attributed to the changing lifestyle and environmental factors. This, in turn, is expected to drive the demand for brain pacemakers over the forecast period.
- Growing awareness about brain pacemakers: There is a growing awareness among people about the benefits of using brain pacemakers. This is primarily due to increasing number of studies that are highlighting the benefits of using these devices in patients with various neurological conditions. This, in turn, is expected to boost demand for brain pacemakers over the forecast period.
- Technological advancements: The technology used in manufacturing brain pacemakers continues to evolve at a rapid pace offering better treatment outcomes for patients suffering from various neurological conditions..This trend is likely to continue over the forecast period, thereby propelling growth of this market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Brain Pacemaker Market Research Report
By Type
Single Channel, Dual Channel
By Application
Dystonia, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder, Parkinson's Disease, Others
By Companies
PINS, Medtronic, Scene Ray, Boston Scientific, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Brain Pacemaker Market Report Segments:
The global Brain Pacemaker market is segmented on the basis of:
Types
Single Channel, Dual Channel
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dystonia, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder, Parkinson's Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PINS
- Medtronic
- Scene Ray
- Boston Scientific
- Abbott
Highlights of The Brain Pacemaker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Channel
- Dual Channel
- By Application:
- Dystonia
- Epilepsy
- Essential Tremor
- Obsessive-Compulsive Disorder
- Parkinson's Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Brain Pacemaker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A brain pacemaker is a medical device that helps to treat certain types of epilepsy. It is a small, battery-powered device that is placed under the skin on the chest or neck. The pacemaker sends electrical impulses to help control seizures.
Some of the major companies in the brain pacemaker market are PINS, Medtronic, Scene Ray, Boston Scientific, Abbott.
The brain pacemaker market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Brain Pacemaker Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Brain Pacemaker Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Brain Pacemaker Market - Supply Chain
4.5. Global Brain Pacemaker Market Forecast
4.5.1. Brain Pacemaker Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Brain Pacemaker Market Size (000 Units) and Y-o-Y Growth
4.5.3. Brain Pacemaker Market Absolute $ Opportunity
5. Global Brain Pacemaker Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Brain Pacemaker Market Size and Volume Forecast by Type
5.3.1. Single Channel
5.3.2. Dual Channel
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Brain Pacemaker Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Brain Pacemaker Market Size and Volume Forecast by Application
6.3.1. Dystonia
6.3.2. Epilepsy
6.3.3. Essential Tremor
6.3.4. Obsessive-Compulsive Disorder
6.3.5. Parkinson's Disease
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Brain Pacemaker Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Brain Pacemaker Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Brain Pacemaker Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Brain Pacemaker Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Brain Pacemaker Demand Share Forecast, 2019-2026
9. North America Brain Pacemaker Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Brain Pacemaker Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Brain Pacemaker Market Size and Volume Forecast by Application
9.4.1. Dystonia
9.4.2. Epilepsy
9.4.3. Essential Tremor
9.4.4. Obsessive-Compulsive Disorder
9.4.5. Parkinson's Disease
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Brain Pacemaker Market Size and Volume Forecast by Type
9.7.1. Single Channel
9.7.2. Dual Channel
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Brain Pacemaker Demand Share Forecast, 2019-2026
10. Latin America Brain Pacemaker Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Brain Pacemaker Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Brain Pacemaker Market Size and Volume Forecast by Application
10.4.1. Dystonia
10.4.2. Epilepsy
10.4.3. Essential Tremor
10.4.4. Obsessive-Compulsive Disorder
10.4.5. Parkinson's Disease
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Brain Pacemaker Market Size and Volume Forecast by Type
10.7.1. Single Channel
10.7.2. Dual Channel
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Brain Pacemaker Demand Share Forecast, 2019-2026
11. Europe Brain Pacemaker Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Brain Pacemaker Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Brain Pacemaker Market Size and Volume Forecast by Application
11.4.1. Dystonia
11.4.2. Epilepsy
11.4.3. Essential Tremor
11.4.4. Obsessive-Compulsive Disorder
11.4.5. Parkinson's Disease
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Brain Pacemaker Market Size and Volume Forecast by Type
11.7.1. Single Channel
11.7.2. Dual Channel
11.8. Basis Point Share (BPS) Anlysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Brain Pacemaker Demand Share, 2019-2026
12. Asia Pacific Brain Pacemaker Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Brain Pacemaker Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Brain Pacemaker Market Size and Volume Forecast by Application
12.4.1. Dystonia
12.4.2. Epilepsy
12.4.3. Essential Tremor
12.4.4. Obsessive-Compulsive Disorder
12.4.5. Parkinson's Disease
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Brain Pacemaker Market Size and Volume Forecast by Type
12.7.1. Single Channel
12.7.2. Dual Channel
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Brain Pacemaker Demand Share, 2019-2026
13. Middle East & Africa Brain Pacemaker Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Brain Pacemaker Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Brain Pacemaker Market Size and Volume Forecast by Application
13.4.1. Dystonia
13.4.2. Epilepsy
13.4.3. Essential Tremor
13.4.4. Obsessive-Compulsive Disorder
13.4.5. Parkinson's Disease
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Brain Pacemaker Market Size and Volume Forecast by Type
13.7.1. Single Channel
13.7.2. Dual Channel
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Brain Pacemaker Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Brain Pacemaker Market: Market Share Analysis
14.2. Brain Pacemaker Distributors and Customers
14.3. Brain Pacemaker Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. PINS
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Scene Ray
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boston Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook